The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry
Open accessAbstract
Bacteriophage (phage) therapy is a promising approach to combat the rise of multidrug-resistant bacteria. Currently, the preferred clinical modality is to pair phage with an antibiotic, a practice thought to improve efficacy. However, antagonism between phage and antibiotics has been reported, the choice of phage and antibiotic is not often empirically determined, and the effect of the host factors on the effectiveness is unknown. Here, we interrogate phage-antibiotic interactions across antibiotics with different mechanisms of action. Our results suggest that phage can lower the working MIC for bacterial strains already resistant to the antibiotic, is dependent on the antibiotic class and stoichiometry of the pairing, and is dramatically influenced by the host microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Cappello, V., Marchetti, L., Parlanti, P., Landi, S., Tonazzini, I., Cecchini, M., Piazza, V., & Gemmi, M. (2016) · Scientific Reports · doi:10.1038/s41598-016-0001-8 · Cited by 13,097
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
(2016) · Cited by 2,888
Limb proportions show developmental plasticity in response to embryo movement
Pollard, A. S., Charlton, B. G., Hutchinson, J. R., Gustafsson, T., McGonnell, I. M., Timmons, J. A., & Pitsillides, A. A. (2017) · Scientific Reports · doi:10.1038/srep41926 · Cited by 2,364
Pipkins, H. R., Bradshaw, J. L., Keller, L. E., Swiatlo, E., & McDaniel, L. S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0179159 · Cited by 1,338
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Schooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-17 · Cited by 1,254
One Juliet and four Romeos: VeA and its methyltransferases
Sarikaya-Bayram, Ã., Palmer, J. M., Keller, N., Braus, G. H., & Bayram, Ã. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00001 · Cited by 1,148
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
Antibiotic efficacy is linked to bacterial cellular respiration
Lobritz, M. A., Belenky, P., Porter, C. B. M., Gutierrez, A., Yang, J. H., Schwarz, E. G., Dwyer, D. J., Khalil, A. S., & Collins, J. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509743112 · Cited by 773
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
Chan, B. K., Sistrom, M., Wertz, J. E., Kortright, K. E., Narayan, D., & Turner, P. E. (2016) · Scientific Reports · doi:10.1038/srep26717 · Cited by 715
Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages
Manges, A. R., Geum, H. M., Guo, A., Edens, T. J., Fibke, C. D., & Pitout, J. D. D. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00135-18 · Cited by 590
Ingala, M. R., Simmons, N. B., Wultsch, C., Krampis, K., Speer, K. A., & Perkins, S. L. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00803 · Cited by 501
Phage-Antibiotic Synergy (PAS): β-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth
Comeau, A., Tétart, F., Trojet, S. N., Prère, M. F., & Krisch, H. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000799 · Cited by 488
Price, L. B., Johnson, J. R., Aziz, M., Clabots, C., Johnston, B., Tchesnokova, V., Nordstrom, L., Billig, M., Chattopadhyay, S., Stegger, M., et al. (2013) · mBio · doi:10.1128/mbio.00377-13 · Cited by 464
Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms
Chaudhry, W. N., Concepción-Acevedo, J., Park, T., Andleeb, S., Bull, J. J., & Levin, B. R. (2017) · PLOS ONE · doi:10.1371/journal.pone.0168615 · Cited by 394
Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy
Tagliaferri, T. L., Jansen, M., & Horz, H.-P. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00022 · Cited by 345
Harper, D., Parracho, H., Walker, J., Sharp, R., Hughes, G., Werthén, M., Lehman, S., & Morales, S. (2014) · Antibiotics · doi:10.3390/antibiotics3030270 · Cited by 342
Oechslin, F., Piccardi, P., Mancini, S., Gabard, J., Moreillon, P., Entenza, J. M., Resch, G., & Que, Y.-A. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw632 · Cited by 325
Pires, D., Melo, L., Vilas Boas, D., Sillankorva, S., & Azeredo, J. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.09.004 · Cited by 312
Evolutionary Rationale for Phages as Complements of Antibiotics
Torres-Barceló, C., & Hochberg, M. E. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2015.12.011 · Cited by 308
Early clinical experience of bacteriophage therapy in 3 lung transplant recipients
Aslam, S., Courtwright, A. M., Koval, C., Lehman, S. M., Morales, S., Furr, C.-L. L., Rosas, F., Brownstein, M. J., Fackler, J. R., Sisson, B. M., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15503 · Cited by 285
Slinker, B. K. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0655 · Cited by 277
Melkonian, C., Gottstein, W., Blasche, S., Kim, Y., Abel-Kistrup, M., Swiegers, H., Saerens, S., Edwards, N., Patil, K. R., Teusink, B., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01347 · Cited by 275
Thomas, P., Sekhar, A. C., Upreti, R., Mujawar, M. M., & Pasha, S. S. (2015) · Biotechnology Reports · doi:10.1016/j.btre.2015.08.003 · Cited by 263
Poolman, J. T., & Wacker, M. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv429 · Cited by 246
A century of phage research: Bacteriophages and the shaping of modern biology
Keen, E. C. (2015) · BioEssays · doi:10.1002/bies.201400152 · Cited by 242
Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro
Ryan, E. M., Alkawareek, M. Y., Donnelly, R. F., & Gilmore, B. F. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00977.x · Cited by 240
Current State of Compassionate Phage Therapy
McCallin, S., Sacher, J. C., Zheng, J., & Chan, B. K. (2019) · Viruses · doi:10.3390/v11040343 · Cited by 227
Kamal, F., & Dennis, J. J. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.02850-14 · Cited by 224
Schlosser, J., Dähnert, L., Dremsek, P., Tauscher, K., Fast, C., Ziegler, U., Gröner, A., Ulrich, R. G., Groschup, M. H., & Eiden, M. (2018) · Viruses · doi:10.3390/v11010001 · Cited by 221
Reversing Bacterial Resistance to Antibiotics by Phage-Mediated Delivery of Dominant Sensitive Genes
Edgar, R., Friedman, N., Molshanski-Mor, S., & Qimron, U. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.05741-11 · Cited by 217
Phage therapy: The peculiar kinetics of self-replicating pharmaceuticals
Payne, R. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109520 · Cited by 216
Tkhilaishvili, T., Winkler, T., Müller, M., Perka, C., & Trampuž, A. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00924-19 · Cited by 179
Akturk, E., Oliveira, H., Santos, S. B., Costa, S., Kuyumcu, S., Melo, L. D. R., & Azeredo, J. (2019) · Antibiotics · doi:10.3390/antibiotics8030103 · Cited by 172
Adapted Bacteriophages for Treating Urinary Tract Infections
Ujmajuridze, A., Chanishvili, N., Goderdzishvili, M., Leitner, L., Mehnert, U., Chkhotua, A., Kessler, T. M., & Sybesma, W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01832 · Cited by 163
Mendonça, N., Leitão, J., Manageiro, V., Ferreira, E., & Caniça, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01412-06 · Cited by 160
Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa
Knezevic, P., Curcin, S., Aleksic, V., Petrusic, M., & Vlaski, L. (2013) · Research in Microbiology · doi:10.1016/j.resmic.2012.08.008 · Cited by 159
Phage therapy: Current status and perspectives
Górski, A., Międzybrodzki, R., Węgrzyn, G., Jończyk‐Matysiak, E., Borysowski, J., & Weber‐Dąbrowska, B. (2020) · Medicinal Research Reviews · doi:10.1002/med.21593 · Cited by 159
Coulter, L. B., McLean, R. J. C., Rohde, R. E., & Aron, G. M. (2014) · Viruses · doi:10.3390/v6103778 · Cited by 129
Smith, K. P., & Kirby, J. E. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00433-18 · Cited by 128
Hesse, S. E., & Adhya, S. L. (2019) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090817-062535 · Cited by 122
Kirby, A. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051017 · Cited by 120
Constructing and Characterizing Bacteriophage Libraries for Phage Therapy of Human Infections
Gibson, S., Green, S. I., Liu, C. G., Salazar, K. C., Clark, J. R., Terwilliger, A. L., Kaplan, H. B., Maresso, A. W., Trautner, B. W., & Ramig, R. F. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02537 · Cited by 110
Self-citationNumerous cultivated and uncultivated viruses encode ribosomal proteins
Mizuno, C. M., Guyomar, C., Roux, S., Lavigne, R., Rodríguez‐Valera, F., Sullivan, M. B., Gillet, R., Forterre, P., & Krupovìč, M. (2019) · Nature Communications · doi:10.1038/s41467-019-08672-6 · Cited by 108
The Many Lives of Nontuberculous Mycobacteria
Claeys, T. A., & Robinson, R. (2018) · Journal of Bacteriology · doi:10.1128/jb.00739-17 · Cited by 106
Kougias, P., Campanaro, S., Treu, L., Tsapekos, P., Armani, A., & Angelidaki, İ. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.01244-18 · Cited by 97
Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa
Lin, Y., Chang, R. Y. K., Britton, W. J., Morales, S., Kutter, E. M., & Chan, H. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.024 · Cited by 95
Urinary tract infections attributed to diverse ExPEC strains in food animals: evidence and data gaps
Singer, R. S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00028 · Cited by 93
Gestal, M. C., Tomás, M., Molina, F., Moure, R., Villanueva, R., & Bou, G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2308-2313.2004 · Cited by 91
Sequential Combined Effect of Phages and Antibiotics on the Inactivation of Escherichia coli
Lopes, A. S., Pereira, C., & Almeida, A. (2018) · Microorganisms · doi:10.3390/microorganisms6040125 · Cited by 81
Green, S. I., Kaelber, J. T., Ma, L. M., Trautner, B. W., Ramig, R. F., & Maresso, A. W. (2017) · Scientific Reports · doi:10.1038/srep46151 · Cited by 76
Self-citationFundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics
Vinks, A. A. T. M. M., Mouton, J. W., & Derendorf, H. (2013) · Springer eBooks · doi:10.1007/978-0-387-75613-4 · Cited by 65
Gonzalez, F., Helm, R. F., Broadway, K. M., & Scharf, B. E. (2018) · Journal of Bacteriology · doi:10.1128/jb.00363-18 · Cited by 51
Ogbolu, D. O., Alli, O. A. T., Webber, M. A., Oluremi, A. S., & Oloyede, O. M. (2018) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2017.00012 · Cited by 48
Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation
Cooper, C. J., Koonjan, S., & Nilsson, A. S. (2018) · Pharmaceuticals · doi:10.3390/ph11020034 · Cited by 37
Patel, M. P., Fryszczyn, B. G., & Palzkill, T. G. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00618-15 · Cited by 25
Cited by
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Phage Therapy for Antibiotic-Resistant Bacterial Infections
Hatfull, G. F., Dedrick, R. M., & Schooley, R. T. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-080219-122208 · Cited by 571
Pirnay, J.-P., Djebara, S., Steurs, G., Griselain, J., Cochez, C., De Soir, S., Glonti, T., Spiessens, A., Vanden Berghe, E., Green, S., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01705-x · Cited by 474
Self-citationConsiderations for the Use of Phage Therapy in Clinical Practice
Suh, G. A., Lodise, T. P., Tamma, P. D., Knisely, J. M., Alexander, J., Aslam, S., Barton, K. D., Bizzell, E., Totten, K. M. C., Campbell, J. L., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02071-21 · Cited by 378
Self-citationNick, J. A., Dedrick, R. M., Gray, A. L., Vladar, E. K., Smith, B. E., Freeman, K. G., Malcolm, K. C., Epperson, L. E., Hasan, N. A., Hendrix, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.04.024 · Cited by 251
“Under various conditions, in vitro studies of combined use of phage and ll OPEN ACCESSArticle antibiotics have identified additive, synergistic, antagonistic, or no effects (Gu Liu et al., 2020).”
Background
Metadata
- Authors
- Gu Liu, C., Green, S. I., Min, L., Clark, J. R., Salazar, K. C., Terwilliger, A. L., Kaplan, H. B., Trautner, B. W., Ramig, R. F., & Maresso, A. W.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2020-08-25
- Volume
- 11
- Issue
- 4
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- OpenAlex
- W3047234466
- Cited by
- 409
- References
- 59
- FWCI
- 20.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.